ABT vs ATOM · P/E 25, rev $44.33B vs rev $135.0K
Abbott Laboratories (ABT) versus Atomera Inc (ATOM) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. ATOM currently screens at market cap $341.1M.
Not investment advice. Open the ABT and ATOM stock pages for the full models.
Not investment advice.